Skip to content

13F-HR filed by Ponoi Management, LLC

Ponoi Management, LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 5 holding rows worth $170,018,000.

Accession
0000950123-21-007097
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 5 entries on the cover page, a total value of $170,018,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $170,018,000 with VALUE read as thousands by filing date, 13F file number 028-19916. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock1,880,623$43,988,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM1,298,908$37,759,000thousands by filing date
RAPT THERAPEUTICS INC75382E109COM1,599,417$35,507,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock685,011$31,428,000thousands by filing date
NURIX THERAPEUTICS INC67080M103COMMON STOCK686,274$21,336,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-21-007097this filing2021-05-17acceptance time not in the bulk data set